Company intelligence / Profile preview

Integra Pharm

Ownership: Private
Development stage: Commercial

Overview

The companies operate primarily as distributors or wholesalers of approved pharmaceutical products. The US entity distributes both generic and branded medications directly to pharmacies in 34 states. The Egyptian company has a portfolio focused on gynecology, pediatrics, and obesity clinics with a competitive pipeline tailored to market needs but no specific clinical trial data disclosed.

Therapeutic areas: OtherWomen's HealthEndocrinologyInfectious Diseases
Modalities: Small molecule
Industry: Non-Academic Healthcare

Partnerships

GALT Pharmaceuticals

Beyond the preview

Go deeper on Integra Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integra Pharm.

Explore the full profile